Skip to content

Company information lookup

BIOPROSPECT LIMITED (BPO)

Development of diagnostic heart rate variability technology for mental health diagnosis

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
BPO 0.004 0% 0.003 0.004 0.004 0.004 0.004 10,637,500

BIOPROSPECT LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code BPO
Securities
Official Listing Date 29 January, 2001
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.bioprospect.com
Registered Office Address c/- CoySec Services, Suite 605, Level 6, 50 Clarence Street, SYDNEY, NSW, AUSTRALIA, 2000
Head Office Telephone +61 2 9299 9580
Head Office Fax +61 2 9299 9501
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
117 VICTORIA STREET, WEST END, QLD, AUSTRALIA, 4101
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Vince Fayad (Non Exec. Chairman, Non Exec. Director)
Mr Claude Solitario (Executive Director)
Ms Silvi Elkhouri (Non Exec. Director)
Mr Kris David Knauer (Non Exec. Director)
Mr Robert Lees (CFO)
Company Secretary Mr Robert Lees
Principal Activities Development of diagnostic heart rate variability technology for mental health diagnosis

BIOPROSPECT LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
10/09/2014   Change in substantial holding 27 PDF
09/09/2014   Final Director's Interest Notice 2 PDF
09/09/2014   Final Director's Interest Notice 2 PDF
09/09/2014   Initial Director's Interest Notice 2 PDF
08/09/2014 asterix BPO to Acquire 100% of Invatec & undertake Corporate Restruc 8 PDF
04/09/2014 asterix Trading Halt 2 PDF
29/08/2014 asterix Preliminary Final Report 39 PDF
31/07/2014 asterix Appendix 4C - quarterly 5 PDF
10/07/2014 asterix Stephen Pearce, Fortescue Metals CFO, joins BPO as Advisor 2 PDF
03/07/2014   Final Director's Interest Notice 2 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
12 Sep 2014 0.004 0% 0.004 0.004 24,509,595
11 Sep 2014 0.004 0% 0.004 0.004 200,000
10 Sep 2014 0.004 0% 0.004 0.004 5,200,000
09 Sep 2014 0.004 0% 0.004 0.004 122,000
08 Sep 2014 0.004 -20% 0.004 0.004 130,673,405

* Volume of shares shown represents only those shares traded on ASX.

BIOPROSPECT LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security BPO. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security BPO

Warrants & Structured Products

No warrants & Structured Products are available over the security BPO

ASX CFDs

No Contracts For Differences are available over the security BPO